Signa Vitae
Journal Title
- Signa Vitae
ISSN
- E 1845-206X | P 1334-5605 | 1845-206X | 1334-5605
Publisher
- Pharmamed Mado Ltd.
Listed on(Coverage)
| JCR | 2008-2019 |
|---|---|
| SJR | 2009-2019 |
| CiteScore | 2011-2019 |
| SCIE | 2010-2021 |
| SCOPUS | 2017-2020 |
| EMBASE | 2016-2020 |
Active
- Active
based on the information
- SCOPUS:2020-10
Country
- CROATIA
Aime & Scopes
- The journal Signa Vitae has been assigned the Impact Factor of 0,2. This fact is clear evidence that we are on the right path in achieving our vision, and hereby we would like to thank those of you who have so far contributed to the project and made this possible at a very early stage. Signa Vitae has been indexed in: Science Citation Index Expanded (SCI), SCOPUS, Chemical Abstracts, Scientific Commons, IndexCopernicus, EBSCOhost®, Directory of Open Access Journals (DOAJ), Electronic Journals Online Library (EJOL), Geneva Foundation for Medical Education and Research, CAB Abstracts, and Global Health. The vision of Signa Vitae is to be the leading journal in intensive care and emergency medicine by the year 2020. The mission of Signa Vitae is to serve professionals dedicated to intensive care and emergency medicine, as a tool for easier and more effective knowledge and experience sharing, with the ultimate goal to improve patients’ outcome. To achieve the goals we have set, Signa Vitae needs your support and contribution. We kindly ask you to publish your articles in Signa Vitae, to cite Signa Vitae in other publications, and to spread this information among your colleagues.